{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:24:55Z","timestamp":1761895495571},"reference-count":39,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":355,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Brazilian Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["478687\/2008-7"],"award-info":[{"award-number":["478687\/2008-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.vaccine.2012.06.069","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T16:58:47Z","timestamp":1341593927000},"page":"5482-5486","source":"Crossref","is-referenced-by-count":22,"title":["Immunogenicity of a meningococcal serogroup C conjugate vaccine in HIV-infected children, adolescents, and young adults"],"prefix":"10.1016","volume":"30","author":[{"given":"Daniela Vinhas","family":"Bertolini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Scarlazzari","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inneke Marie","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena Keiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helo\u00edsa Helena","family":"de Sousa Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.06.069_bib0005","series-title":"Pediatric AIDS: the challenge of HIV infection in infants, children, and adolescents","first-page":"115","article-title":"Immunopathology and pathogenesis of HIV infection","author":"Rosenberg","year":"1994"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0010","series-title":"Tratado de Infectologia","first-page":"99","article-title":"Manifesta\u00e7\u00f5es Cl\u00ednicas da Aids","author":"Marques","year":"2002"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0015","series-title":"Manual de HIV\/AIDS","first-page":"7","article-title":"Manifesta\u00e7\u00f5es cl\u00ednicas","author":"Rachid","year":"2005"},{"issue":"12","key":"10.1016\/j.vaccine.2012.06.069_bib0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.7326\/0003-4819-123-12-199512150-00007","article-title":"Sporadic meningococcal disease in adults: results of a 5-year population-based study","volume":"123","author":"Stephens","year":"1995","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.vaccine.2012.06.069_bib0025","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/QAD.0b013e32833a2520","article-title":"Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa","volume":"24","author":"Cohen","year":"2010","journal-title":"AIDS"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.06.069_bib0030","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1473-3099(04)01106-5","article-title":"Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children","volume":"4","author":"Obaro","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2012.06.069_bib0035","first-page":"61","article-title":"Immunization of children at risk of infection with human immunodeficiency virus","volume":"81","author":"Moss","year":"2003","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0040","unstructured":"Comit\u00ea Assessor em Terapia Antirretroviral em Crian\u00e7as e Adolescentes Infectados pelo HIV: Minist\u00e9rio da Sa\u00fade do Brasil. Recomenda\u00e7\u00f5es para Terapia Antiretroviral em crian\u00e7as e adolescentes infectados pelo HIV 2009\u2013Suplemento I. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade do Brasil, Secretaria de Vigil\u00e2ncia em Sa\u00fade, Departamento de DST, Aids e Hepatites Virais; 2010."},{"key":"10.1016\/j.vaccine.2012.06.069_bib0045","unstructured":"Coordena\u00e7\u00e3o de Imuniza\u00e7\u00f5es e Auto-Sufici\u00eancia em Imunobiol\u00f3gicos. Manual dos Centros de Refer\u00eancia para Imunobiol\u00f3gicos Especiais. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade do Brasil, Secretaria de Vigil\u00e2ncia \u00e0 Sa\u00fade, Programa Nacional de Imuniza\u00e7\u00f5es; 2006."},{"key":"10.1016\/j.vaccine.2012.06.069_bib0050","unstructured":"Centers for Disease Control and Prevention (CDC), MMWR. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-Exposed and HIV-Infected Children. August 26, 2009\/58(Early Release);1\u2013166. Available at: http:\/\/AIDSinfo.nih.gov.(last accessed 06.26.11)."},{"issue":"3 Suppl.","key":"10.1016\/j.vaccine.2012.06.069_bib0055","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.2223\/JPED.1495","article-title":"Vacinas meningoc\u00f3cicas conjugadas: efic\u00e1cia e novas combina\u00e7\u00f5es","volume":"82","author":"S\u00e1fadi","year":"2006","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.vaccine.2012.06.069_bib0060","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/14760584.5.6.851","article-title":"Long-term protection in children with meningococcal C conjugate vaccination: lessons learned","volume":"5","author":"Borrow","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0065","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2005.03.045","article-title":"Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain","volume":"23","author":"Larrauri","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.06.069_bib0070","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/IAI.72.1.332-337.2004","article-title":"Immune response to meningococcal serogroup C conjugate vaccine in asplenic individuals","volume":"72","author":"Balmer","year":"2004","journal-title":"Infection and Immunity"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0075","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/pbc.21174","article-title":"Immune response to conjugated meningococcal C vaccine in pediatric oncology patients","volume":"49","author":"Yu","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.vaccine.2012.06.069_bib0080","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.22399","article-title":"Safety and efficacy of meningococcal c vaccination in juvenile idiopatic arthritis","volume":"56","author":"Zonneveld-Huijssoon","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.vaccine.2012.06.069_bib0085","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/01.inf.0000187027.45918.6a","article-title":"Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants","volume":"24","author":"Collins","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0090","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/bjs.6008","article-title":"Mode of splenectomy and immunogenicity of meningococcal vaccination in patients with hereditary spherocytosis","volume":"95","author":"Stoehr","year":"2008","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.vaccine.2012.06.069_bib0095","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/INF.0b013e3181c38f3b","article-title":"Phase I\/II, open-label trial of safety and immunogenicity of meningococcal (Groups A,C,Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents","volume":"29","author":"Siberry","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0100","series-title":"Designing clinical research","first-page":"65","article-title":"Estimating sample size and power: the nitty\u2013gritty","author":"Browner","year":"1998"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0105","unstructured":"Sposito AC, Caramelli B, Fonseca FA, et al. IV Diretriz Brasileira sobre Dislipidemias e Preven\u00e7\u00e3o de Aterosclerose. S\u00e3o Paulo: Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia; 2007."},{"key":"10.1016\/j.vaccine.2012.06.069_bib0110","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus, I: the role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2012.06.069_bib0115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The multilaboratory study group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2012.06.069_bib0120","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.32.6.1475-1482.1994","article-title":"Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay","volume":"32","author":"Gheesling","year":"1994","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.06.069_bib0125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/CDLI.2.2.132-137.1995","article-title":"Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992","volume":"2","author":"Holder","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1473-3099(04)01251-4","article-title":"Meningococcal polysaccharide-protein conjugate vaccines","volume":"5","author":"Snape","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0135","series-title":"Vaccines","first-page":"959","article-title":"Meningococcal vaccines","author":"Granoff","year":"2004"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0140","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0145","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal conjugated vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0150","unstructured":"Centers for Disease Control and Prevention (CDC), MMWR.Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). May 27, 2005\/54 (n(RR-7). Available at: http:\/\/www.cdc.gov\/mmwr\/pdf\/rr\/rr5407.pdf (last accessed 06.27.11)."},{"key":"10.1016\/j.vaccine.2012.06.069_bib0155","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(75)92125-X","article-title":"Effect of group-A meningococcal vaccine in army recruits in Finland","volume":"2","author":"Makela","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0160","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM197709292971302","article-title":"Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age","volume":"297","author":"Peltola","year":"1977","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2012.06.069_bib0165","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/CDLI.2.2.132-137.1995","article-title":"Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentration to the new standard reference serum CDC1992","volume":"2","author":"Holder","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1574-695X.2002.tb00608.x","article-title":"Neisseria meningitidis serogroup B: laboratory correlates of protection","volume":"34","author":"Vermont","year":"2002","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"12 Suppl.","key":"10.1016\/j.vaccine.2012.06.069_bib0175","doi-asserted-by":"crossref","first-page":"S285","DOI":"10.1097\/01.inf.0000147654.03890.b9","article-title":"Meningococcal vaccines","volume":"23","author":"Danzig","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0180","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1016\/j.vaccine.2009.01.076","article-title":"Seroprevalence of bactericidal antibody against Neisseria meningitidis serogroup C in pre-vaccinal era: the Italian epidemiological scenario","volume":"27","author":"Gasparini","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0185","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/S0264-410X(00)00050-5","article-title":"Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial","volume":"18","author":"Choo","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0190","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/bmj.39563.545255.AE","article-title":"Seroprotection against serogroup C meningococcal disease in adolescents in United Kingdom: observational study","volume":"336","author":"Snape","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2012.06.069_bib0195","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1542\/peds.2011-2380","article-title":"Meningococcal conjugate vaccines policy update: booster dose recommendations","volume":"128","year":"2011","journal-title":"Pediatrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12009474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12009474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T14:13:28Z","timestamp":1642688008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12009474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":39,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0264410X12009474"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.06.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}